Skip to content
10-Q

Quarterly Report

Medpace Holdings, Inc. MEDP

0001668397-24-000168

← back to feed
Filed
Oct 22, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Oct 18, 2024 31.08M sh
Cash And Equivalents Q3 2024 · Sep 30, 2024 $656.9M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $245.45M
Current Liabilities Q3 2024 · Sep 30, 2024 $1.04B
Current Liabilities Q3 2024 · Dec 31, 2023 $925.13M
Total Liabilities Q3 2024 · Sep 30, 2024 $1.2B
Total Liabilities Q3 2024 · Dec 31, 2023 $1.1B
Current Assets Q3 2024 · Sep 30, 2024 $1.03B
Current Assets Q3 2024 · Dec 31, 2023 $593.83M
Total Assets Q3 2024 · Sep 30, 2024 $2.08B
Total Assets Q3 2024 · Dec 31, 2023 $1.66B
Shares Diluted Q3 2024 · Sep 30, 2023 31.76M sh
Shares Diluted Q3 2024 · Sep 30, 2023 31.84M sh
Stock Repurchased Q3 2024 · Sep 30, 2023 $144.02M
Capex Q3 2024 · Sep 30, 2023 $26.66M
Operating Cash Flow Q3 2024 · Sep 30, 2023 $276.98M
Stockholders Equity Q3 2024 · Sep 30, 2023 $470.91M
Stockholders Equity Q3 2024 · Jun 30, 2023 $391.06M
Stockholders Equity Q3 2024 · Mar 31, 2023 $347.26M
Stockholders Equity Q3 2024 · Dec 31, 2022 $386.39M
Eps Diluted Q3 2024 · Sep 30, 2023 $2.22
Eps Diluted Q3 2024 · Sep 30, 2023 $6.42
Eps Basic Q3 2024 · Sep 30, 2023 $2.30
Eps Basic Q3 2024 · Sep 30, 2023 $6.65
Sga Expense Q3 2024 · Sep 30, 2023 $41.41M
Sga Expense Q3 2024 · Sep 30, 2023 $118.84M
Net Income Q3 2024 · Sep 30, 2023 $70.55M
Net Income Q3 2024 · Sep 30, 2023 $204.51M
Net Income Q3 2024 · Jun 30, 2023 $61.07M
Net Income Q3 2024 · Mar 31, 2023 $72.89M
Operating Income Q3 2024 · Sep 30, 2023 $84.91M
Operating Income Q3 2024 · Sep 30, 2023 $249.51M
Revenue Q3 2024 · Sep 30, 2023 $492.5M
Revenue Q3 2024 · Sep 30, 2023 $1.39B